AZD6280

DRUG4 trials

Sponsors

AstraZeneca

Conditions

AnxietyHealthyHealthy Volunteer

Phase 1

AZD6280 Multiple Ascending Dose Study

CompletedNCT00681317

AstraZenecaHealthy Volunteer

Start: 2008-03-31End: 2008-07-31Updated: 2010-12-09

Positron Emission Tomography (PET) Study With (11C) Flumazenil to Determine Central GABAA Receptor Occupancy of AZD6280

CompletedNCT00681746

AstraZenecaAnxiety

Start: 2008-02-29End: 2008-09-30Target: 8Updated: 2010-12-10

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

CompletedNCT00750802

AstraZenecaHealthy Volunteer

Start: 2008-09-30End: 2008-12-31Updated: 2009-06-26

Effect of Multiple Doses of AZD6280 on the Pharmacokinetics of Midazolam (CYP3A4) and Caffeine (CYP1A2)

CompletedNCT00824057

AstraZenecaHealthy

Start: 2009-01-31End: 2009-03-31Updated: 2009-07-31